Inventor · disambiguated record
Nicholas M. Marshall
Also filed as: MARSHALL NICHOLAS · MARSHALL NICHOLAS M · MARSHALL NICHOLAS MICHAEL
15 granted patents·4 pending applications·20 citations·filing 2015–2025
89Inventor score
Top patents by PatentIndex Score
19 records- 0193US9975959B2Administration of kynurenine depleting enzymes for tumor therapyUNIV TEXAS·Filed 2015·Granted May 22, 2018·8 cites·16 claims
- 0291US12012618B2Engineered galactose oxidase variant enzymesCODEXIS INC·Filed 2022·Granted Jun 18, 2024·1 cites·15 claims
- 0391US11168142B2Administration of kynurenine depleting enzymes for tumor therapyUNIV TEXAS·Filed 2018·Granted Nov 9, 2021·5 cites·20 claims
- 0489US11795445B2Engineered phosphopentomutase variant enzymesCODEXIS INC·Filed 2021·Granted Oct 24, 2023·1 cites·12 claims
- 0587US12252723B2Ketoreductase polypeptides and polynucleotidesCODEXIS INC·Filed 2023·Granted Mar 18, 2025·0 cites·6 claims
- 0687US11034948B2Engineered phosphopentomutase variant enzymesCODEXIS INC·Filed 2019·Granted Jun 15, 2021·2 cites·24 claims
- 0786US12480099B2Engineered galactose oxidase variant enzymesCODEXIS INC·Filed 2024·Granted Nov 25, 2025·0 cites·18 claims
- 0886US12421509B2Engineered phosphopentomutase variant enzymesCODEXIS INC·Filed 2023·Granted Sep 23, 2025·0 cites·18 claims
- 0986US11466259B2Engineered galactose oxidase variant enzymesCODEXIS INC·Filed 2019·Granted Oct 11, 2022·2 cites·29 claims
- 1084US2025027094A1Engineered purine nucleoside phosphorylase variant enzymesCODEXIS INC·Filed 2024·Application pending·0 cites
- 1182US11162105B2Engineered purine nucleoside phosphorylase variant enzymesCODEXIS INC·Filed 2019·Granted Nov 2, 2021·1 cites·5 claims
- 1276US11746369B2Ketoreductase polypeptides and polynucleotidesCODEXIS INC·Filed 2021·Granted Sep 5, 2023·0 cites·6 claims
- 1375US12110493B2Engineered purine nucleoside phosphorylase variant enzymesCODEXIS INC·Filed 2021·Granted Oct 8, 2024·0 cites·10 claims
- 1475US2025207171A1Ketoreductase polypeptides and polynucleotidesCODEXIS INC·Filed 2025·Application pending·0 cites
- 1570US2022275099A1Administration of kynurenine depleting enzymes for tumor therapyUNIV TEXAS·Filed 2021·Application pending·0 cites
- 1669US11021729B2Ketoreductase polypeptides and polynucleotidesCODEXIS INC·Filed 2018·Granted Jun 1, 2021·0 cites·8 claims
- 1767US2025353910A1Multispecific binding agents that target b7h3 and gd2 and uses thereofINVENRA INC·Filed 2024·Application pending·0 cites
- 1864US12312418B2Orthogonal mutations for heterodimerizationINVENRA INC·Filed 2021·Granted May 27, 2025·0 cites·1 claims
- 1955US12503688B2Engineered transaminase polypeptidesCODEXIS INC·Filed 2020·Granted Dec 23, 2025·0 cites·27 claims
Join the waitlist — get patent alerts
Get an alert when Nicholas M. Marshall files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →